IL6 and amyotrophic lateral sclerosis: Subsequently, through a paired study analyzing serum cytokine levels pre- and post-ALS, a nonrandomized clinical trial found that three consecutive courses of ALS treatment significantly decreased the plasma levels of 32 cytokines, including IL-6 and TNF-α (44).